July 3, 2019 06:26 AM EDT

Roche’s new flu drug continues to rack up PhIII successes — but can it beat generic Tamiflu with outcomes like this?

Roche’s campaign to create a successor to Tamiflu took one step forward today with the news that Xofluza was well tolerated in children …

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

BECOME A PREMIUM SUBSCRIBER

Roche’s new flu drug con­tin­ues to rack up PhI­II suc­cess­es — but can it beat gener­ic Tam­i­flu with out­comes like this?